From: Chemo-immunotherapy improves long-term survival in a preclinical model of MMR-D-related cancer
Drug | IC50 value [μM] | ||
---|---|---|---|
MLH1−/− A7450 T1 M1a | MLH1−/−  328 | MLH1−/−  1351 | |
GEM | 0.05 | 0.07 | < 0.02 |
Cisplatin | 0.63 | 0.05 | 0.06 |
5-FU | 2.15 | 3.57 | 1.00 |
CPX | > 300 | > 300 | > 300 |